Clinical Trial

Safety and Efficacy of Romiplostim in Treatment of Chronic ITP in Children

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim is to evaluate safety and efficacy of Romiplostim in the treatment of chronic ITP in children
Trial Details
NCT Number NCT07214025
Lead Sponsor Assiut University
Conditions Romiplostim N01, ITP
Enrollment 100 participants
Start Date 2025-11-01
Primary Completion 2026-11-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-09